Menu
Cart 0
Continuous Glucose Monitoring (CGM) Market

Continuous Glucose Monitoring (CGM) Market - Forecasts from 2018 to 2023

  • $3,800.00
  • Publishing Date: February 2017
  • Format: pdf
Sample Request

The global Continuous Glucose Monitoring market is projected to witness a CAGR of XX% during the forecast period to reach a total market size of US$XXXX million by 2023, increasing from US$ XXX million in 2017. Continuous glucose monitoring devices are latest advancement in the field of diabetes management. CGM devices have the ability to alert a diabetes patient of impending hypoglycemic/ hyperglycemic events and thereby enables the patient to avoid extreme hypoglycemic/hyperglycemic conditions. It is anticipated that continuous glucose monitoring devices uses constant feedback from glucose sensor to activate the insulin delivery pump. Depending on whether continuous glucose monitoring device penetrates or breaks the skin and the sample is measured extracorporeally. There is a large requirement of glucose monitoring devices for diagnosis and treatment of diabetes. Hence, a rise in the diabetic population drives the market by increasing the use of glucose monitoring devices. The other factors, like technological innovations, convenience of monitoring device, early detection of hypoglycemia and hyperglycemic diabetes are the major drivers for the market.  Conversely, high prices of devices and calibration issues are key factors that can inhibit market growth.

In terms of end user of continuous glucose monitoring, the global market is segmented as hospitals, diagnostic center & clinics and home health care. The growing prevalence of diabetes in growing economies has pushed the demand of continuous glucose monitoring devices in hospitals and diagnostic centers.

Geographically, the global continuous glucose monitoring market is segmented as North America, Europe, Middle East & Africa, Asia -Pacific and South America. North-America and Europe is considered to be the largest market for the continuous glucose monitoring, mainly due to the new product launches, adoption of new technologies and increasing product awareness in these regions.

The global Continuous glucose monitoring market is competitive wowing to the presence of the well diversified global players. However, some big international players dominate the market with their prices, advancement in the technology and higher accuracy for detecting diabetes. Major players in the continuous glucose monitoring market include Roche Diagnostics, Dexcom Inc, Abbott Laboratories, Bayer AG, Nova Biomedical Corporation, GlySens Inc., Medtronic Inc, Insulet Corporation, Animas Corporation, Ypsomed AG, and Sensionics Inc.

Segmentation

Continuous glucose monitoring devices market is segmented on the basis of by product type, by application, end user and by geography. 

  • By product type
    • Transmitters & Receivers
    • Insulin Pumps
    • Sensors
  • By Application
    • Diabetic Patients
    • Critical care Patients
  • By End User
    • Hospitals
    • Diagnostics centers and clinics
    • Home Health care
  • By Geography
    • North America
      • United States
      • Canada
      • Mexico
      • Others
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • Germany
      • France
      • Italy
      • United Kingdom
      • Others
    • Middle East and Africa
      • Israel
      • Saudi Arabia
      • South Africa
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Others

Key Questions answered by the report

  • What is the global continuous glucose monitoring market size from 2018 to 2023?
  • How are the major drivers and restraints affecting the continuous glucose monitoring market and the opportunities which exist for the key vendors?
  • Which segment and region will drive or lead the market growth and why?
  • A comprehensive analysis of competitive landscape and key market participants behavior
  • Key strategies being adopted by vendors, with in-depth analysis of their impact on competition and market growth.
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. Global Continuous glucose monitoring Market Forcast By Product Type (US $ billion)
5.1. Transmitters & Receivers
5.2. Insulin Pumps
5.3. Sensors
6. Global Continuous glucose monitoring Market Forecast By Application (US $ billion)
6.1 Diabetic Patients
6.2 Critical Care Patients
7. Global Continuous glucose monitoring Market Forecast By End User (US $ billion)
7.1 Hospitals
7.2 Diagnostic Center and Clinics
7.3 Home health care.
8. Global Wood floor Adhesive Market Forecast By Geography (US $ billion)
8.1. North America
8.1.1. United States
8.1.2. Canada
8.1.3. Mexico
8.1.4. Others
8.2. South America
8.2.1. Brazil
8.2.2. Argentina
8.2.3. Others
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. Italy
8.3.4. United Kingdom
8.3.5. Others
8.4. Middle East and Africa
8.4.1. Israel
8.4.2. Saudi Arabia
8.4.3. South Africa
8.4.4. Others
8.5. Asia Pacific
8.5.1. Japan
8.5.2. China
8.5.3. India
8.5.4. Australia
8.5.5. Others
9. COMPETITIVE INTELLIGENCE
9.1. Recent Deals and Investment
9.2. Strategies of Key Players
9.3. Investment Analysis
10. COMPANY PROFILES
9.1 Dexcom Inc,
9.1.1 Company Overview
9.1.2 Financials
9.1.3 Production and Services
9.1.4 SWOT Analysis
9.2 Abbott Laboratories.
9.2.1 Company Overview
9.2.2 Financials
9.2.3 Product and Services
9.2.4 SWOT Analysis
9.3 Bayer AG
9.3.1 Company Overview
9.3.2 Financials
9.3.3 Product and Services
9.3.4 SWOT Analysis
9.4 Nova Biomedical Corporation
9.4.1 Company Overview
9.4.2 Financials
9.4.3 Product and Services
9.4.4 SWOT Analysis
9.5 GlySens Incorporated
9.5.1 Company Overview
9.5.2 Financials
9.5.3 Product and Services
9.5.4 SWOT Analysis
9.6 Medtronic Inc,
9.6.1 Company Overview
9.6.2 Financials
9.6.3 Product and Services
9.6.4 SWOT Analysis
9.7 Insulet Corporation
9.7.1 Company Overview
9.7.2 Financials
9.7.3 Product and Services
9.7.4 SWOT Analysis
9.8 Animas Corporation,
9.8.1 Company Overview
9.8.2 Financials
9.8.3 Product and Services
9.8.4 SWOT Analysis
9.9 Ypsomed AG,
9.9.1 Company Overview
9.9.2 Financials
9.9.3 Product and Services
9.9.4 SWOT Analysis
9.10 Sensionics Inc.
9.10.1 Company Overview
9.10.2 Financials
9.10.3 Product and Services
9.10.4 SWOT Analysis

Related Reports
Back to the top